[Aflatoxin effect on bacteria].
D000348:Aflatoxins / Q000494:pharmacology*; D001410:Bacillus megaterium / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D004357:Drug Synergism; D004492:Edetic Acid / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D008365:Manometry; D009268:Nalidixic Acid / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013501:Surface-Active Agents / Q000494:pharmacology
D000348:Aflatoxins; D013501:Surface-Active Agents; D003609:Dactinomycin; D009268:Nalidixic Acid; D004492:Edetic Acid
Untersuchungen über die Aflatoxinwirkung auf Bakterien.